Evidence map›Paper›PMID 39483444›Full record

ArticleGlobal health & medicine2024

Non-acquired immunodeficiency syndrome defining malignancies in people living with haemophilia and human immunodeficiency virus after direct-acting antiviral era.

Michiko Koga, Akari Fukuda, Masanori Nojima, Aya Ishizaka, Toshihiro Itoh, Susumu Eguchi, Tomoyuki Endo, Akiko Kakinuma, Ei Kinai, Tomomi Goto and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Global health & medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Michiko KogaDivision of Infectious Diseases, Advanced Clinical Research Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Akari FukudaDivision of Infectious Diseases, Advanced Clinical Research Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Masanori NojimaCentre for Translational Research, The Institute of Medical Science Hospital, The University of Tokyo, Tokyo, Japan.
Aya IshizakaDivision of Infectious Diseases, Advanced Clinical Research Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Toshihiro ItohDepartment of Infectious Diseases, NHO Sendai Medical Centre, Miyagi, Japan.
Susumu EguchiDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Tomoyuki EndoDepartment of Hematology, Hokkaido University Hospital, Hokkaido, Japan.
Akiko KakinumaSocial Welfare Corporation Habataki Welfare Project, Tokyo, Japan.
Ei KinaiDepartment of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
Tomomi GotoSocial Welfare Corporation Habataki Welfare Project, Tokyo, Japan.
Shunji TakahashiDepartment of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Hiroki TakedaSocial Welfare Corporation Habataki Welfare Project, Tokyo, Japan.
Takahiro TanakaDivision of Infectious Diseases, Advanced Clinical Research Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Katsuji TeruyaAIDS Clinical Centre, The National Centre for Global Health and Medicine, Tokyo, Japan.
Jugo HanaiMedical Care and Human Rights Network, Osaka, Japan.
Teruhisa FujiiDivision of Transfusion Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Junko FujitaniDepartment of Rehabilitation, National Centre for Global Health and Medicine, Tokyo, Japan.
Takashi HosakaDivision of Infectious Diseases, Advanced Clinical Research Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Eiji MitaDepartment of Gastroenterology and Hepatology, NHO Osaka National Hospital, Osaka, Japan.
Rumi MinamiDepartment of Internal Medicine, Immunology and Infectious Diseases, Clinical Research Centre, NHO Kyushu Medical Centre, Fukuoka, Japan.
Hiroshi MoroDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yoshiyuki YokomakuClinical Research Centre, NHO Nagoya Medical Centre, Aichi, Japan.
Dai WatanabeAIDS Medical Centre, NHO Osaka National Hospital, Osaka, Japan.
Tamayo WatanabeDepartment of Immunology and Infectious Disease, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
Hiroshi YotsuyanagiDivision of Infectious Diseases, Advanced Clinical Research Centre, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-acquired immunodeficiency syndrome-defining malignancies (NADMs) are the crucial cause of mortality in people living with haemophilia and human immunodeficiency virus (PLWHH). We aimed to analyse the types and characters of NADMs in PLWHH after approval of direct-acting antivirals (DAA), considering that most PLWHH are infected with hepatitis C virus (HCV). We conducted a nationwide questionnaire mail survey across 395 HIV core facilities in Japan between May 2022 and February 2023. Eight-year data from 64 respondent hospitals (

Indexed as

haemophiliaHCVHIVliver cancernon-AIDS-defining cancersSCIR

Identifiers

PMID39483444
PMCPMC11514628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.